News of the WeekAIDS VACCINE RESEARCH

Thumbs Down on Expensive, Hotly Debated Trial of NIH AIDS Vaccine

See allHide authors and affiliations

Science  25 Jul 2008:
Vol. 321, Issue 5888, pp. 472
DOI: 10.1126/science.321.5888.472

You are currently viewing the summary.

View Full Text

Summary

When he scuttled plans for a $63 million AIDS vaccine efficacy trial last week, Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, challenged researchers to come up with a "lean and mean" alternative.